Evaluation of a program for long-term treatment of Duchenne muscular dystrophy - Experience at the university hospitals of Cleveland

被引:47
|
作者
Vignos, PJ
Wagner, MB
Karlinchak, B
Katirji, B
机构
[1] UNIV HOSP CLEVELAND, MUSCLE DIS CTR, CLEVELAND, OH 44106 USA
[2] UNIV HOSP CLEVELAND, DEPT NEUROL, CLEVELAND, OH 44106 USA
来源
关键词
D O I
10.2106/00004623-199612000-00007
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
One hundred and forty-four boys who had Duchenne muscular dystrophy were managed at a single center between 1953 and 1994 and were followed for a mean of 8.9 years. The long duration of follow-up provided an opportunity to examine the effects of physical therapy and orthopaedic treatment on contractures of the lower extremities and on the duration of the ability to walk. Contractures of the lower extremities were controlled best when patients were managed with a combination of daily passive stretching exercises, prescribed periods of standing and walking, tenotomy of the Achilles tendon, posterior tibial-tendon transfer, and application of knee-ankle-foot orthoses. Approximately two years after bracing, the severity of the contracture of the heel cords was similar in the patients who had had an operation and those who had not. By the fourth year after bracing, however, the patients who had had an operation had less severe contractures than those who had had bracing alone. Five to seven years after the operation and bracing, control of contractures was still good, especially for the patients who had had posterior tibial-tendon transfer. Contracture of the knee was well controlled five to seven years after bracing in all patients who had had bracing, with or without an operation. The program enabled the patients who had been managed with bracing to walk until a mean age of 13.6 years. After loss of the ability to walk with bracing, the ability to stand continued for an additional two years with use of orthoses. The findings of the present study demonstrate the value of traditional methods of operative treatment and bracing for controlling contractures of the lower extremities in patients who have Duchenne muscular dystrophy and for prolonging their ability to walk.
引用
收藏
页码:1844 / 1852
页数:9
相关论文
共 50 条
  • [31] Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment
    Wong, Brenda L.
    Rybalsky, Irina
    Shellenbarger, Karen C.
    Tian, Cuixia
    McMahon, Mary A.
    Rutter, Meilan M.
    Sawnani, Hemant
    Jefferies, John L.
    [J]. JOURNAL OF PEDIATRICS, 2017, 182 : 296 - 303
  • [32] Side effects of long-term prednisone treatment in Duchenne dystrophy
    Pandya, S
    Moxley, RT
    Griggs, RC
    King, W
    Signore, L
    Mendell, JR
    Kissel, JT
    Florence, J
    Schierbecker, J
    Pestronk, A
    Robinson, J
    Fenichel, G
    Mathieson-Burden, N
    Brooke, MH
    [J]. ANNALS OF NEUROLOGY, 2000, 48 (03) : 469 - 469
  • [33] Oral bisphosphonate treatment in patients with Duchenne muscular dystrophy on long term glucocorticoid therapy
    Tian, Cuixia
    Wong, Brenda L.
    Hornung, Lindsey
    Khoury, Jane C.
    Rybalsky, Irina
    Shellenbarger, Karen C.
    Rutter, Meilan M.
    [J]. NEUROMUSCULAR DISORDERS, 2020, 30 (07) : 599 - 610
  • [34] Intermittent, low dosage prednisolone in the long term treatment of early Duchenne muscular dystrophy
    Dubowitz, V
    Kinali, M
    Mercuri, E
    Main, M
    Muntoni, F
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (08): : 1182 - 1182
  • [35] Long-Term Characterization of In Vivo Genome Editing in a Mouse Model of Duchenne Muscular Dystrophy
    Nelson, Christopher
    Gemberling, Matthew
    Madhavan, Sarina
    Rivera, Ruth M. Castellanos
    Asokan, Aravind
    Gersbach, Charles A.
    [J]. MOLECULAR THERAPY, 2017, 25 (05) : 100 - 101
  • [36] Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
    Caroline Le Guiner
    Laurent Servais
    Marie Montus
    Thibaut Larcher
    Bodvaël Fraysse
    Sophie Moullec
    Marine Allais
    Virginie François
    Maeva Dutilleul
    Alberto Malerba
    Taeyoung Koo
    Jean-Laurent Thibaut
    Béatrice Matot
    Marie Devaux
    Johanne Le Duff
    Jack-Yves Deschamps
    Inès Barthelemy
    Stéphane Blot
    Isabelle Testault
    Karim Wahbi
    Stéphane Ederhy
    Samia Martin
    Philippe Veron
    Christophe Georger
    Takis Athanasopoulos
    Carole Masurier
    Federico Mingozzi
    Pierre Carlier
    Bernard Gjata
    Jean-Yves Hogrel
    Oumeya Adjali
    Fulvio Mavilio
    Thomas Voit
    Philippe Moullier
    George Dickson
    [J]. Nature Communications, 8
  • [37] Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
    Le Guiner, Caroline
    Servais, Laurent
    Montus, Marie
    Larcher, Thibaut
    Fraysse, Bodvael
    Moullec, Sophie
    Allais, Marine
    Francois, Virginie
    Dutilleul, Maeva
    Malerba, Alberto
    Koo, Taeyoung
    Thibaut, Jean-Laurent
    Matot, Beatrice
    Devaux, Marie
    Le Duff, Johanne
    Deschamps, Jack-Yves
    Barthelemy, Ines
    Blot, Stephane
    Testault, Isabelle
    Wahbi, Karim
    Ederhy, Stephane
    Martin, Samia
    Veron, Philippe
    Georger, Christophe
    Athanasopoulos, Takis
    Masurier, Carole
    Mingozzi, Federico
    Carlier, Pierre
    Gjata, Bernard
    Hogrel, Jean-Yves
    Adjali, Oumeya
    Mavilio, Fulvio
    Voit, Thomas
    Moullier, Philippe
    Dickson, George
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [38] Long-term follow-up of dysphagia in adult patients with Duchenne muscular dystrophy
    Yamada, Yuka
    Kawakami, Michiyuki
    Wada, Ayako
    Fukui, Shogo
    Haruyama, Koshiro
    Otsuka, Tomoyoshi
    Liu, Meigen
    [J]. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2018, 22 (05) : 786 - 790
  • [39] Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients
    Rice, Melissa L.
    Wong, Brenda
    Horn, Paul S.
    Yang, Michael B.
    [J]. JOURNAL OF AAPOS, 2018, 22 (03): : 192 - 196
  • [40] Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapy
    Mayo, A. L.
    Craven, B. C.
    McAdam, L. C.
    Biggar, W. D.
    [J]. NEUROMUSCULAR DISORDERS, 2012, 22 (12) : 1040 - 1045